Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study — Stella

Recruiting

Back to Primary Sclerosing Cholangitis trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Stanford University, Stanford, California

Key details

Phase

Very early testing

Sponsor

Stanford University

Enrollment target

~15 participants

Started

May 2023

Primary completion

May 2027

Age range

18 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov